Low-priced drug incentive plan haunts drug makers

Local pharmaceutical manufacturers are attentively watching the government’ movement to implement the controversial low-priced drug incentive plan.

Pharmaceutical sources said the government is likely to make public within this week a set of measures to rationalize rising medication costs covered by the state health insurance, which has seen its payments increase rapidly over the past few ye...